Literature DB >> 20701533

Combination lipid therapy in type 2 diabetes.

Christoph H Saely, Philipp Rein, Heinz Drexel.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20701533     DOI: 10.1056/NEJMc1006407

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

1.  Sensitive cardiac troponin T assay and the risk of incident cardiovascular disease in women with and without diabetes mellitus: the Women's Health Study.

Authors:  Brendan M Everett; Nancy R Cook; Maria C Magnone; Maria Bobadilla; Eunjung Kim; Nader Rifai; Paul M Ridker; Aruna D Pradhan
Journal:  Circulation       Date:  2011-05-31       Impact factor: 29.690

2.  Observational study to evaluate the safety and efficacy of saroglitazar in Indian diabetic dyslipidemia patients.

Authors:  Sadanand R Shetty; Soumitra Kumar; R P Mathur; Kamal H Sharma; Ashok D Jaiswal
Journal:  Indian Heart J       Date:  2015-02-26

Review 3.  The role of triglyceride in cardiovascular disease in asian patients with type 2 diabetes--a systematic review.

Authors:  Ai-Hua Chen; Chin-Hsiao Tseng
Journal:  Rev Diabet Stud       Date:  2013-08-10

4.  Interactive effects of a common γ-glutamyltransferase 1 variant and low high-density lipoprotein-cholesterol on diabetic macro- and micro-angiopathy.

Authors:  Hideaki Jinnouchi; Kazunori Morita; Takahiro Tanaka; Ayami Kajiwara; Yuki Kawata; Kentaro Oniki; Junji Saruwatari; Kazuko Nakagawa; Koji Otake; Yasuhiro Ogata; Akira Yoshida; Seiji Hokimoto; Hisao Ogawa
Journal:  Cardiovasc Diabetol       Date:  2015-05-08       Impact factor: 9.951

Review 5.  Impact of peroxisome proliferator-activated receptor-α on diabetic cardiomyopathy.

Authors:  Lin Wang; Yin Cai; Liguo Jian; Chi Wai Cheung; Liangqing Zhang; Zhengyuan Xia
Journal:  Cardiovasc Diabetol       Date:  2021-01-04       Impact factor: 9.951

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.